US Stocks
US Options
Emerging Asia
GBP Cash Savings
Charts & Tools
Paper Trading
Extended Hours
Overview
Desktop
Wall Street JournalH
HCM
Hutchmed (China) Limited
19.42
-0.39-1.97%Closed16:00 10/17 EDT
OPEN/PREV CLOSE19.89/19.81
TODAY RANGE19.32-19.98
VOL79.58K
MARKET CAP3.38B
52 WEEK RANGE11.93-21.92
AVG VOL (3M)110.46K
% TURNOVER0.05%
TURNOVER0
P/E (TTM)-77.7733
% RANGE2.83%
EPS(TTM)-0.2497
P/E(FORWARD)-61.7684
P/B4.573
BVPS4.247
DIVIDEND--
P/S20.19
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP3.38B
SHARES OUTSTANDING174.29M
NEXT EARNINGS--
FREE FLOAT174.08M
LOT SIZE1
EX-DIV DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·1d ago
Hutchmed announces results from SAVANNAH trial
Seeking Alpha·10/04 17:55
Chinese biotechs gain as drugmakers targeted in new security bill said to mull divestments
NASDAQ·09/13 20:33
HUTCHMED (HCM) Shares Cross Above 200 DMA
Seeking Alpha·08/30 11:43
HUTCHMED pulls regulatory submission for Takeda-partnered cancer drug in China
NASDAQ·08/23 15:49
HUTCHMED (HCM) Shares Cross Below 200 DMA
Benzinga·08/15 18:52
Hutchmed scores U.S. success with cancer drug, but profits still dip
Seeking Alpha·08/09 06:08
Hutchmed Growing Sales By 64% In H1 2024
TipRanks·08/05 10:24
Robust Sales and Expansion Potential Underpin Buy Rating for HUTCHMED
Dow Jones·08/01 17:45
HUTCHMED (China) Is Maintained at Neutral by Goldman Sachs
Dow Jones·08/01 17:45
HUTCHMED (China) Price Target Raised to $19.00/Share From $17.00 by Goldman Sachs
Same Industry
Name/Symbol
Change%
Price